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The relationship between uncertainty tolerance and
oncologists’ perceptions of large-panel genomic tumor testing
Eric Anderson1, Alexandra Hinton1, Christine Lary1, Kimberly Murray1, Leo Waterston1, Paul Han1
Maine Cancer Genomics Initiative*
1Center

for Outcomes Research and Evaluation, Maine Medical Center Research Institute

Introduction
Large-panel genomic tumor testing (GTT) is a new technology that promises to
make cancer treatment more precise, but that currently poses many uncertainties
regarding its clinical value and appropriate use. Uncertainty Tolerance (UT), a
psychological construct that describes trait-level differences in individuals’
responses to uncertainty, may influence oncologists’ perceptions and attitudes
regarding GTT.

Association between perceived uncertainty and attitudes and self-efficacy
Uncertainty Tolerance:
Ambiguity
Tolerance
(AAMED)

Methods

* p=0.035
(β=0.15)

Perceived
uncertainty about
GTT

Sample. 57 Community-based oncologists participating in a statewide study
of large-panel GTT in routine oncology care completed surveys assessing their
perceptions and attitudes regarding GTT.

Risk
Tolerance
(PRA)

p=0.057
(β=0.13)

p=0.7
(β=0.04)

Measures.

Complexity
Tolerance
(TFA)

* p=0.037
(β=0.23)

Perceived uncertainty about GTT (1-item): Genomic tumor testing seems uncertain

Self-efficacy about GTT (4-items, α = 0.82): Confidence in:
…ability to interpret results
…ability to explain results
…ability to make appropriate treatment decisions
…your practice’s ability to implement GTT
Uncertainty Tolerance (UT). Separate subscales assessed tolerance of 3 types
of uncertainty: ambiguity, risk, and complexity

Ambiguity Tolerance (AAMED)
Positive

If I am uncertain about the responsibilities involved in a particular task, I get very anxious.
I don’t like to work on a problem unless there is a possibility of getting a clear-cut and unambiguous answer.
A good task is one in which what is to be done and how it is to be done are always clear.

self-efficacy and attitudes regarding GTT was explored using GLMs.
Oncologists’ UT was assessed as a moderator.

Gender
Female
Practice location
Rural
Small town
Suburban
Urban

Years of Experience
1-4
5-9
10-19
20-29
30+

1 (1.9%)
7 (13%)
23 (43%)
13 (24%)
10 (19%)

Specialty
Hematology/Oncology
Surgery
Gynecology
Urology
Neurology

47 (84%)
4 (7.1%)
2 (3.6%)
1 (1.8%)
1 (1.8%)

26 (46%)

17 (30%)
15 (26%)
12 (21%)
9 (16%)

Attitudes

High tolerance
Low tolerance

* p = 0.035

* p = 0.037
Certain

Uncertain

Perceived uncertainty
about GTT

Certain

Uncertain

Notes: For this figure, participants median split
by different types of uncertainty tolerance into
high/low groups.

•

Oncologists’ perceived uncertainty about GTT is associated with their global
attitudes towards GTT. Higher uncertainty is associated with more negative
attitudes.

•

Moreover, this relationship is moderated by individual differences in oncologists’
uncertainty tolerance (UT). Greater UT buffers the relationship between
uncertainty and negative attitudes. Furthermore, UT appears to have differential
effects depending on the type of uncertainty (ambiguity, risk, complexity).

•

More research is needed to understand the mechanisms by which UT influences
perceptions, attitudes, and practices regarding GTT and other uncertain medical
interventions.

Statistical Analysis. The relationship between perceived uncertainty and

Study sample (N = 57)

Complexity Tolerance (TFA)

Extremely
confident

Complexity Tolerance (Geller Tolerance for Ambiguity Scale; Geller et al., 1990)

Sample Characteristics

Risk Tolerance (PRA)

Conclusions

I try to avoid situations that have uncertain outcomes.
Taking risks does not bother me if the gains involved are high.
I rarely, if ever, take risks when there is another alternative.

Results

β=-0.11; p=0.24

Negative

I would not have confidence in a medical test or treatment if experts had conflicting opinions about it.
I would not be afraid of trying a medical test or treatment even if experts had conflicting opinions about it.
If experts had conflicting opinions about a medical test or treatment, I would still be willing to try it.

Risk Tolerance (Pearson Risk Attitude Scale; Pearson et al., 1995)

Self-efficacy about GTT

p=0.6
(β=0.05)

Moderating effect of uncertainty tolerance

Not at all
confident

Ambiguity Tolerance (Han Ambiguity in Medicine Scale; Han et al., 2009)

* β=-0.21; p<0.001

Self-efficacy

Attitudes about GTT (8-items, α = 0.67): GTT seems:
…beneficial
…harmful *
…accurate
…unproven *
…trustworthy, complicated, inefficient *, worthwhile
* reverse coded

Attitudes about GTT

p=0.25
(β=0.07
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